State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing, Gulou District, 210009, China.
State Key Laboratory of Natural Medicines, Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 24 Tongjia Xiang, Nanjing, Gulou District, 210009, China.
Biochem Biophys Res Commun. 2019 Feb 19;509(4):937-942. doi: 10.1016/j.bbrc.2019.01.028. Epub 2019 Jan 14.
Aptamers are short, single-stranded oligonucleotides that bind to their targets with high affinity and specificity. Usually, aptamers are selected experimentally using SELEX approach. Here, we describe a computational approach for selection of aptamers for proteins, which involves generation of a virtual library of sequences, modeling of their 3D-structures and selection of perspective aptamers through docking, molecular dynamics simulation, binding free energy calculations and finally estimating the experimental affinity. Using this method, a 15-mer RNA aptamer was designed for epithelial cell adhesion molecule. Flow cytometry and fluorescence microscopy results reviled that RNA1 aptamer interacts specifically with human cancer cells that express EpCAM, but not with the EpCAM negative cells. The binding affinity of the RNA1 aptamer to MCF-7 and MDA-MB-231 is approximately 21.8 and 96.9 nM respectively. This novel RNA aptamer will help in the future development of targeted therapeutics and molecular imaging.
适体是短的、单链的寡核苷酸,与它们的靶标具有高亲和力和特异性结合。通常,适体是通过 SELEX 方法进行实验选择的。在这里,我们描述了一种用于蛋白质适体选择的计算方法,该方法涉及生成一个虚拟序列文库,对其三维结构进行建模,并通过对接、分子动力学模拟、结合自由能计算和最终估计实验亲和力来选择有前景的适体。使用这种方法,设计了一个针对上皮细胞黏附分子的 15 个核苷酸 RNA 适体。流式细胞术和荧光显微镜结果表明,RNA1 适体与表达 EpCAM 的人癌细胞特异性相互作用,但与 EpCAM 阴性细胞不相互作用。RNA1 适体与 MCF-7 和 MDA-MB-231 的结合亲和力分别约为 21.8 和 96.9 nM。这种新型 RNA 适体将有助于未来靶向治疗和分子成像的发展。